Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Dry Needling on Neck and Shoulder Pain in Orchestral Musicians: a Prospective Case Series

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03402867
Recruitment Status : Completed
First Posted : January 18, 2018
Last Update Posted : July 6, 2018
Sponsor:
Information provided by (Responsible Party):
Aitor Martin-Pintado Zugasti, CEU San Pablo University

Brief Summary:
This study evaluates the effectiveness of Deep dry needling of active myofascial trigger points present in muscles of the neck and shoulder region in orchestral musicians.

Condition or disease Intervention/treatment Phase
Pain Syndrome Musculoskeletal Pain Trigger Point Pain, Myofascial Procedure: Deep dry needling Phase 1 Phase 2

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 8 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: Deep dry needling
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effects of Myofascial Trigger Point Dry Needling on Neck Pain in Orchestral Musicians
Actual Study Start Date : February 1, 2018
Actual Primary Completion Date : March 1, 2018
Actual Study Completion Date : March 5, 2018

Arm Intervention/treatment
Experimental: Intervention
Deep dry needling applied on active myofascial trigger points in the shoulder and neck regions
Procedure: Deep dry needling
Insertion of a filiform needle in the active trigger point of musculoskeletal muscle




Primary Outcome Measures :
  1. Visual analogue scale for pain [ Time Frame: 2 weeks ]
    Pain measurement. 100-mm visual analog scale (VAS), horizontal line ranging from 0mm (no pain) to 100mm (worst imaginable pain).


Secondary Outcome Measures :
  1. Pressure pain threshold [ Time Frame: 2 weeks ]
    Analogic algometer

  2. Neck disability index (NDI) [ Time Frame: 2 weeks ]
    10-item, 50-point index that assesses different aspects of daily functioning in patients with neck pain. It assesses four items regarding subjective symptoms (pain intensity, headache, concentration, sleeping), four items regarding activities of daily living (lifting, work, driving, recreation), and two items regarding discretionary activities of daily living (personal care, reading). Each item is scored 0 to 5, with the total reported as either a raw score (0-50) or as a percentage score. Higher values represent a worse outcome.

  3. Shoulder pain disability index (SPADI) [ Time Frame: 2 weeks ]
    Self-administered questionnaire, grouping 13 questions, 5 of which measure the severity of pain caused by various arm movements involving the shoulder, the pain being assessed on a numeric pain scale ranging from 0 to 10. Eight additional questions related to functional impairments of the shoulder are assessed with a numeric scale. Higher values represent a worse outcome.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Orchestral musicians
  • Chronic neck or shoulder pain
  • Presence of active myofascial trigger points

Exclusion Criteria:

  • Fear of needles
  • Coagulation disorders
  • Pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03402867


Locations
Layout table for location information
Spain
CEU San Pablo University
Madrid, Comunidad De Madrid, Spain, 28668
Sponsors and Collaborators
CEU San Pablo University
Layout table for additonal information
Responsible Party: Aitor Martin-Pintado Zugasti, PhD, CEU San Pablo University
ClinicalTrials.gov Identifier: NCT03402867    
Other Study ID Numbers: CEU-012
First Posted: January 18, 2018    Key Record Dates
Last Update Posted: July 6, 2018
Last Verified: July 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Musculoskeletal Pain
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Pain
Neurologic Manifestations